United States· US:51662-1688_564adf55-3c43-498c-e063-6294a90a5600
VASOPRESSIN
A medicinal product containing vasopressin, registered in United States by HF Acquisition Co LLC, DBA HealthFirst.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VASOPRESSIN
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1151662-1688-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vasopressin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArgipressin 20units/1ml solution for injection ampoulesAOP Orphan Ltd
- SwitzerlandEmpressin, Konzentrat zur Herstellung einer InfusionslösungOrPha Swiss GmbH
- GermanyArgipressin FarmakAspire Pharma (Malta) Limited
- FinlandEmpressinOrpha-Devel Handels und Vertriebs GmbH
- PolandArgipressin FarmakFarmak International Sp. z o.o.
- SwedenEmbesin 40 IE/2 ml Koncentrat till infusionsvätska, lösningOrifarm AB
- CanadaVASOPRESSIN INJECTION USPSANDOZ CANADA INCORPORATED
- IrelandEmbesin 20 IU/ml concentrate for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Empesin
- Belgium · Reverpleg
- Bulgaria · Емпресин
- Czechia · Embesin
- Germany · Argipressin Farmak, Empressin
- Denmark · Empressin
- Estonia · Empesin
- Spain · Empressin
- Finland · Empressin
- France · Reverpleg
- United Kingdom (Northern Ireland) · Argipressin Aop, Argipressin Mercury Pharmaceuticals
- Greece · Empressin
- Croatia · Empressin
- Hungary · Embesyn
- Ireland · Embesin
- Italy · Empressin
- Lithuania · Empesin
- Luxembourg · Reverpleg
- Latvia · Empesin
- Netherlands · Empressine
- Norway · Empressin
- Poland · Argipressin Farmak, Empesin
- Portugal · Empressin
- Romania · Reverpleg
- Sweden · Empressin
- Slovenia · Empesin
- Slovakia · Embesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad651fb0-f86a-4017-9345-2af163d528de GET /v1/drugs/ad651fb0-f86a-4017-9345-2af163d528de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "20",
"substance": "VASOPRESSIN",
"productndc": "51662-1688",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "[USP'U]/mL",
"application_number": "NDA212593",
"marketing_category": "NDA"
}See everything about vasopressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.